208 related articles for article (PubMed ID: 19490762)
1. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
[TBL] [Abstract][Full Text] [Related]
2. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
[TBL] [Abstract][Full Text] [Related]
5. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Kotwal J; Bhargava M
Hematology; 2018 Aug; 23(7):413-416. PubMed ID: 29338606
[TBL] [Abstract][Full Text] [Related]
6. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
Kar R; Mishra P; Pati HP
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
[TBL] [Abstract][Full Text] [Related]
8. Use of capillary blood to diagnose hereditary spherocytosis.
Crisp RL; Solari L; Gammella D; Schvartzman GA; Rapetti MC; Donato H
Pediatr Blood Cancer; 2012 Dec; 59(7):1299-301. PubMed ID: 22488885
[TBL] [Abstract][Full Text] [Related]
9. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.
Watanabe T; Ono H; Tajima I; Ishigaki H; Hakamata A; Shirai M; Endoh A; Hongo T
Pediatr Int; 2014 Jun; 56(3):427-9. PubMed ID: 24894931
[TBL] [Abstract][Full Text] [Related]
10. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
[TBL] [Abstract][Full Text] [Related]
11. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
[TBL] [Abstract][Full Text] [Related]
12. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
[TBL] [Abstract][Full Text] [Related]
13. Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
Andres O; Eber S; Speer CP
Ann Hematol; 2015 Dec; 94(12):1959-64. PubMed ID: 26336967
[TBL] [Abstract][Full Text] [Related]
14. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina.
Crisp RL; Solari L; Vota D; García E; Miguez G; Chamorro ME; Schvartzman GA; Alfonso G; Gammella D; Caldarola S; Riccheri C; Vittori D; Venegas B; Nesse A; Donato H
Ann Hematol; 2011 Jun; 90(6):625-34. PubMed ID: 21080168
[TBL] [Abstract][Full Text] [Related]
15. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
[TBL] [Abstract][Full Text] [Related]
17. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of hereditary spherocytosis in North India.
Panigrahi I; Phadke SR; Agarwal A; Gambhir S; Agarwal SS
J Assoc Physicians India; 2002 Nov; 50():1360-7. PubMed ID: 12583462
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
[TBL] [Abstract][Full Text] [Related]
20. [Flowcytometric diagnostics of hereditary spherocytosis].
Riley CH; Nikolajsen K; Kjaersgaard E; Klausen TW; Mourits-Andersen T; Clausen N; Lausen B; Rosthøj S; Birgens H
Ugeskr Laeger; 2009 Nov; 171(49):3610-4. PubMed ID: 19954702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]